General Information of the Compound
| Compound ID |
CP0520199
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-[3-[3-tert-butyl-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide;hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H29ClF3N5O2
|
||||||||||||||||||
| Molecular Weight |
523.987
|
||||||||||||||||||
| Canonical SMILES |
Cl.CC(C)(C)c1cc(ccc1OCc1ccc(cc1)C(F)(F)F)-c1noc(n1)[C@@H]1CCCN1C(N)=N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H28F3N5O2.ClH/c1-24(2,3)18-13-16(21-31-22(35-32-21)19-5-4-12-33(19)23(29)30)8-11-20(18)34-14-15-6-9-17(10-7-15)25(26,27)28;/h6-11,13,19H,4-5,12,14H2,1-3H3,(H3,29,30);1H/t19-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AGZNVEMVNPCKSX-FYZYNONXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01766, Sphingosine kinase 1
Protein ID: PT01765, Sphingosine kinase 2